Interactive Case-Lecture Series:
Advances in Treating Metastatic Castration Resistant Prostate Cancer
UroToday premiers a new, case study-based, mini-lecture series for clinicians treating urologic cancers, specifically metastatic castrate-resistant prostate cancer (mCRPC).
The series currently includes 3 lectures with more to be added.To read more, a FREE Urotoday registration is required. Click here to register or login above.